Clinical trial INCA 0186-101
A Phase 1, Open-Label, Multicenter Study of INCA00186 as Monotherapy or in Combination With Immunotherapy in Participants With Advanced Solid Tumors
Organ | Multiple |
---|---|
Trial status | Trial closed |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Incyte Corporate |
EudraCT Identifier | 2021-001263-24 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04989387 |
Last update |